Association between the NQO1 C609T Polymorphism with Hepatocellular Carcinoma Risk in the Chinese Population |
Zhao, Hong
(Department of Radiology, Institute: the Second Hospital of Anhui Medical University)
Zou, Li-Wei (Department of Radiology, Institute: the Second Hospital of Anhui Medical University) Zheng, Sui-Sheng (Department of Radiology, Institute: the Second Hospital of Anhui Medical University) Geng, Xiao-Ping (Department of Radiology, Institute: the Second Hospital of Anhui Medical University) |
1 | Akkiz H, Bayram S, Bekar A, et al (2010). No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects. Asian Pac J Cancer Prev, 11, 1051-8. |
2 | Bowen DG, Walker CM (2005). Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature, 436, 946-52. DOI |
3 | de Lope CR, Tremosini S, Forner A, et al (2012). Management of HCC. J Hepatol, 56, 75-87. |
4 | Dinkova-Kostova AT, Talalay P (2010). NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys, 501, 116-23. DOI |
5 | Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. DOI |
6 | El-Serag HB, Rudolph KL (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-76. DOI |
7 | Farazi PA, DePinho RA (2006). Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer, 6, 674-87. DOI |
8 | Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58. DOI |
9 | Hu X, Zhang Z, Ma D, et al (2010). TP53, MDM2, NQO1, and susceptibility to cervical cancer. Cancer Epidemiol Biomarkers Prev, 19, 755-61. DOI |
10 | Kato N, Ji G, Wang Y, et al (2005). Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C. Hepatology, 42, 846-53. DOI |
11 | Kim YJ, Lee HS (2005). Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Intervirology, 48, 10-5. DOI |
12 | Lau J, Ioannidis JP, Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-6. DOI |
13 | Liu F, Luo L, Wei Y, et al (2013). A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population. Tumour Biol, 34, 47-53. DOI |
14 | Malik MA, Zargar SA, Mittal B (2011). Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley. DNA Cell Biol, 30, 297-303. DOI ScienceOn |
15 | Mandal RK, Nissar K, Mittal RD (2012). Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India. Mol Biol Rep, 39, 11145-52. DOI |
16 | Moher D, Liberati A, Tetzlaff J, et al (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med, 151, 264-9. DOI |
17 | Parkin DM (2001). Global cancer statistics in the year 2000. Lancet Oncol, 2, 533-43. DOI |
18 | Peng XE, Jiang YY, Shi XS, et al (2013). NQO1 609C>T polymorphism interaction with tobacco smoking and alcohol drinking increases colorectal cancer risk in a Chinese population. Gene, 521, 105-10. DOI |
19 | Tan SK, Qiu XQ, Tang GF, et al (2012). Relationship between hepatocellular carcinoma and the interaction between NQO1 polymorphisms and environmental factors. Zhonghua Gan Zang Bing Za Zhi, 20, 833-7. |
20 | Siegel D, Yan C, Ross D (2012). NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones. Biochem Pharmacol, 83, 1033-40. DOI |
21 | Traver RD, Siegel D, Beall HD, et al (1997). Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer, 75, 69-75. DOI |
22 | Wang WW, Chen GY, Sun JJ, et al (2013). The relationship between polymorphisms of NQO1 genes and hepatocellular carcinoma in Zhengzhou and Guilin areas. Chin J Hepatobiliary Surg, 19, 836-40. |
23 | Yuan W, Xu L, Chen W, et al (2011). Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis. Breast Cancer Res Treat, 125, 467-72. DOI |
24 | Yuen MF, Hou JL, Chutaputti A, et al (2009). Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol, 24, 346-53. DOI |